Gov't Lodges Rival Early Win Bid In Gilead HIV Patent Row
By Jasmin Boyce ( November 2, 2022, 7:27 PM EDT) -- The U.S. government has urged a Delaware federal judge to award it partial summary judgment in its patent suit against Gilead Sciences Inc. over two brand name HIV treatments that purportedly violate four government-owned patents, arguing there's no question that Gilead's drug Truvada infringes at least one claim in two of the asserted patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.